XML 62 R46.htm IDEA: XBRL DOCUMENT v3.3.1.900
Related Party Transactions (Details Narrative) - USD ($)
12 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2013
General and administrative expenses $ 2,690,659 $ 1,041,140  
Common stock vested awards $ 250,000    
Common shares to be issued    
Second Stock Option [Member]      
Recognized stock based compensation expense     $ 1,002,500
Number of vested shares 500,000   500,000
Exercise Price $ 1.6   $ 1.6
Expiry date Jul. 05, 2023   Jul. 05, 2023
Restricted Common Stock [Member]      
Non-cash stock option compensation charges $ 1,220,000 $ 610,000  
Common stock vested awards 500,000 250,000  
Additional compensation obligations associated with vesting $ 1,128,064    
Fair value of non-cash stock compensation charges per share $ 2.44    
Common shares to be issued $ 1,000,000    
Directors and Officers [Member]      
Non-cash stock option compensation charges 331,095    
Recognized stock based compensation expense 2,348,064    
Accounts payable and accrued liabilities $ 33,000 $ 28,232  
Directors and Officers [Member] | Share-based Compensation Award, Tranche One [Member] | Restricted Common Stock [Member]      
Stock based compensation award vesting in percentage 25.00%    
Description stock based compensation award vesting

Company starting a Phase Ib/IIb human study.

   
Common shares to be issued $ 610,000    
Directors and Officers [Member] | Share-based Compensation Award, Tranche Two [Member] | Restricted Common Stock [Member]      
Stock based compensation award vesting in percentage 25.00%    
Description stock based compensation award vesting

Company in-licensing additional assets in clinical or pre-clinical stage.

   
Common shares to be issued $ 610,000    
Directors and Officers [Member] | Share-based Compensation Award, Tranche Three [Member] | Restricted Common Stock [Member]      
Stock based compensation award vesting in percentage 25.00%    
Description stock based compensation award vesting

Company securing additional non-dilutive equity funding in 2013 of at least $5,000,000 with a share price higher than the previous funding.

   
Common shares to be issued $ 610,000    
Directors and Officers [Member] | Share-based Compensation Award, Tranche Four [Member] | Restricted Common Stock [Member]      
Stock based compensation award vesting in percentage 25.00%    
Description stock based compensation award vesting

Company obtaining a listing on a major stock exchange.